Toxicology – Whole-Bowel Irrigation (WBI)

Core Concept

Whole-bowel irrigation (WBI) is a gastrointestinal decontamination technique that uses a large volume of an iso-osmotic polyethylene glycol–electrolyte solution (PEG-ELS) to mechanically move intestinal contents through the GI tract.

Unlike activated charcoal, WBI does not adsorb or chemically neutralize a toxin.

Its purpose is:

Rapid intestinal transit → removal of unabsorbed material in stool → reduced opportunity for further absorption

WBI is not routinely indicated for most poisonings. It is reserved for selected exposures in which potentially dangerous material is expected to remain within the gastrointestinal tract.

⸻

Mechanism of Action

PEG-ELS remains predominantly within the intestinal lumen.

Because the solution is approximately iso-osmotic, relatively little net movement of water or electrolytes should occur across the bowel wall.

The large volume produces:

• Intestinal distension
• Increased luminal flow
• Accelerated intestinal transit
• Repeated watery stools

This mechanically carries unabsorbed substances out of the gastrointestinal tract.

⸻

WBI vs Activated Charcoal

These treatments work differently.

Activated Charcoal

Toxin → adsorption to charcoal → reduced GI absorption

Whole-Bowel Irrigation

Toxin-containing intestinal contents → mechanical propulsion → fecal elimination

This makes WBI potentially useful when the substance:

• Is poorly adsorbed by charcoal
• Is contained in sustained/extended-release preparations
• Forms concretions or pharmacobezoars
• Is contained inside drug packets

⸻

Evidence and Modern Role

A major limitation is that evidence showing improved clinical outcomes from WBI is limited.

Therefore:

WBI should not be routinely performed after every potentially toxic ingestion.

The decision should consider:

• Toxicity of the substance
• Amount potentially ingested
• Formulation
• Time since ingestion
• Expected absorption kinetics
• GI motility
• Airway status
• Presence of obstruction or perforation
• Availability of more effective treatments

Poison-center or medical-toxicology consultation is useful when WBI is being considered.

⸻

Major Situations Where WBI May Be Considered

Important selected indications include:

• Sustained- or extended-release drug ingestions
• Enteric-coated preparations in selected severe exposures
• Substances poorly adsorbed by activated charcoal
• Large iron ingestions
• Selected lithium ingestions
• Lead-containing foreign material
• Pharmacobezoars or concretions
• Body packers carrying drug packets

The strength of evidence differs substantially among these situations.

⸻

Extended-Release Preparations

Extended-release medications can remain in the gastrointestinal tract for prolonged periods.

Potentially dangerous delayed absorption can occur with selected:

• Cardiovascular medications
• Lithium preparations
• Theophylline preparations
• Other sustained-release formulations

WBI may be considered after a potentially severe ingestion, particularly when delayed absorption could produce major toxicity.

⸻

Enteric-Coated Drugs

Enteric coatings delay dissolution until the preparation reaches the intestine.

This can result in:

• Delayed absorption
• Delayed peak concentrations
• Prolonged toxicity

WBI may occasionally be considered for substantial ingestion of a dangerous enteric-coated medication, but it is not automatically required for every enteric-coated exposure.

⸻

Iron Poisoning

Activated charcoal does not meaningfully bind iron.

Therefore, WBI may be considered after a substantial ingestion when a significant amount of iron-containing material is believed to remain within the gastrointestinal tract.

Radiopaque tablets may sometimes be visible on abdominal imaging.

However:

WBI does not treat iron that has already been absorbed.

Severe systemic iron toxicity requires supportive care and deferoxamine when indicated.

⸻

Lithium Poisoning

Lithium is also poorly adsorbed by activated charcoal.

WBI may have a role after selected large acute ingestion of sustained-release lithium, particularly while tablets remain within the GI tract.

However, WBI does not remove lithium that has already entered the bloodstream or tissues.

Management of systemic toxicity centers on:

• Appropriate fluid and electrolyte management
• Serial lithium concentrations
• Renal assessment
• Neurologic monitoring
• Hemodialysis in selected severe cases

⸻

Lead-Containing Material

WBI may be useful when lead-containing foreign material or particles remain within the gastrointestinal tract.

Examples can include certain swallowed lead objects or substantial radiopaque lead-containing material.

Management depends on:

• Location
• Object characteristics
• Blood lead concentration
• Symptoms
• Whether material is progressing through the bowel

Some retained foreign bodies require endoscopic or surgical removal rather than WBI.

⸻

Other Heavy Metals

The older source broadly listed arsenic and mercury.

Modern practice is more selective.

WBI should not automatically be used simply because a heavy metal was ingested.

The usefulness depends on:

• Chemical form
• Quantity
• Whether material remains physically within the GI tract
• Radiographic findings when relevant
• Expected absorption
• Clinical toxicity

Chelation and supportive treatment may be much more important once systemic absorption has occurred.

⸻

Pharmacobezoars and Concretions

Some medications can aggregate within the stomach or intestine and produce prolonged absorption.

Possible clues include:

• Unexpectedly prolonged toxicity
• Rising drug concentrations
• Delayed clinical deterioration
• Visible tablet masses on imaging in selected cases

WBI may occasionally assist removal, but a large or persistent bezoar may require:

• Endoscopic evaluation
• Other specialist intervention

⸻

Body Packers

Body packers intentionally swallow or insert multiple carefully wrapped packets, usually for drug smuggling.

Packets are generally designed to survive gastrointestinal transit.

For an asymptomatic patient with intact packets, WBI is commonly considered to accelerate passage under monitored conditions.

⸻

Packet Rupture

Rupture of a drug packet can release a massive amount of concentrated drug.

This may cause rapidly fatal toxicity.

If packet rupture or leakage is suspected, management changes from routine decontamination to an emergency requiring:

• Immediate resuscitation
• Toxin-specific treatment when available
• Urgent surgical consultation when indicated

WBI alone is not adequate treatment for a leaking or ruptured packet.

⸻

Body Stuffers

Body stuffers hurriedly swallow poorly wrapped drugs to avoid detection.

Their packets are generally:

• Smaller
• Fewer
• Less securely packaged

Because rupture is more likely and the exposure pattern differs, body stuffers should not automatically be managed with the same WBI strategy as body packers.

Management is individualized according to drug, packaging, symptoms, and imaging findings.

⸻

Imaging

Imaging can be useful when the ingested material is radiopaque or when packets/foreign bodies are suspected.

Potential applications include:

• Iron tablets
• Lead objects
• Selected foreign bodies
• Body-packer packets

For suspected body packing, CT is generally more sensitive than plain abdominal radiography.

A negative plain film does not reliably exclude packets.

⸻

Contraindication – Bowel Obstruction

WBI should not be performed when mechanical obstruction is suspected.

Large volumes introduced into an obstructed bowel can cause:

• Severe distension
• Recurrent vomiting
• Aspiration
• Worsening bowel injury
• Perforation

⸻

Contraindication – Ileus

Adequate GI motility is necessary for WBI to work.

Patients with ileus may retain the irrigation solution rather than passing it.

Ileus may occur with poisoning from substances such as:

• Antimuscarinic drugs
• Opioids

Markedly reduced bowel sounds, abdominal distension, vomiting, and other findings should therefore be considered before WBI.

⸻

Contraindication – Gastrointestinal Perforation

Suspected or established GI perforation is a contraindication.

Increasing intestinal volume can worsen:

• Leakage
• Peritoneal contamination
• Sepsis

⸻

Airway Protection

WBI involves administration of substantial fluid volumes.

Patients who cannot protect their airway have a significant aspiration risk.

High-risk findings include:

• Marked CNS depression
• Recurrent seizures
• Severe agitation preventing safe administration
• Repeated vomiting
• Loss of airway reflexes

WBI should not be administered through an unsafe airway.

⸻

Important Airway Nuance

A patient should not be intubated solely to make routine WBI possible unless the expected toxicologic benefit clearly justifies the risks of airway intervention.

If intubation is independently necessary because of severe poisoning, WBI can subsequently be considered when otherwise appropriate.

⸻

Hemodynamic Instability

Severely unstable patients are generally poor candidates for immediate WBI.

Initial priorities remain:

Airway → breathing → circulation → toxin-specific stabilization

GI decontamination must never delay resuscitation.

⸻

Common Adverse Effects

WBI commonly causes:

• Nausea
• Vomiting
• Abdominal bloating
• Cramping
• Profuse diarrhea
• Rectal irritation

Poor tolerance frequently limits successful treatment.

⸻

Aspiration

Aspiration is the most concerning acute complication.

Although PEG solution itself has relatively low systemic toxicity, aspirated material may also contain:

• Gastric acid
• Food
• Medication
• Toxic substances

This can result in significant chemical pneumonitis or other pulmonary injury.

⸻

Fluid and Electrolyte Effects

PEG-electrolyte preparations are designed to minimize net fluid and electrolyte shifts.

Nevertheless, abnormalities can occur, particularly in:

• Children
• Older adults
• Renal impairment
• Patients with substantial vomiting
• Prolonged treatment
• Improperly prepared solutions

Clinical and laboratory monitoring should therefore be individualized.

⸻

Correct Preparation Matters

PEG-electrolyte powder must be prepared according to product instructions.

Incorrect concentration can alter osmolality and potentially cause significant electrolyte or fluid abnormalities.

Other cathartic solutions should not be assumed to be equivalent to standard PEG-electrolyte WBI preparations.

⸻

Oral vs Enteral Administration

Cooperative patients may drink PEG-ELS.

When clinically appropriate, administration may also occur through an enteral tube.

However, tube administration does not eliminate:

• Aspiration risk
• Vomiting
• Distension
• Intolerance

The patient’s airway and GI function remain important.

⸻

Treatment Endpoint

The historical endpoint of simply continuing until stool becomes clear is incomplete.

Clear rectal effluent can indicate that bowel contents have been substantially evacuated, but treatment should also consider:

• Clinical course
• Nature of the ingested material
• Whether tablets/packets are still present
• Imaging when appropriate
• Drug concentrations when clinically meaningful

For radiopaque material or body packets, objective confirmation of passage may be useful.

⸻

WBI and Activated Charcoal

Combining WBI with activated charcoal is controversial.

PEG solutions can interfere with charcoal adsorption under some circumstances, while simultaneous administration can also complicate tolerance.

Therefore, the two techniques should not be combined automatically.

The choice depends on the toxin and clinical circumstances.

⸻

Multiple-Dose Activated Charcoal vs WBI

These techniques should not be confused.

WBI

• Removes unabsorbed intestinal contents.

Multiple-dose activated charcoal

• Can enhance elimination of selected already-absorbed drugs by interrupting enteroenteric or enterohepatic recirculation.

Classic drugs for which MDAC may enhance elimination include:

• Carbamazepine
• Dapsone
• Phenobarbital
• Quinine
• Theophylline

The indication for one technique does not automatically imply an indication for the other.

⸻

WBI Does Not Enhance Systemic Elimination

Once a toxin has been absorbed into the bloodstream, WBI generally cannot remove it.

For example:

• Absorbed lithium → dialysis may be required.
• Absorbed iron → deferoxamine may be indicated.
• Absorbed lead → chelation may be indicated.
• Systemic drug toxicity → appropriate antidotal/supportive treatment.

WBI is therefore fundamentally a pre-absorption gastrointestinal intervention.

⸻

Timing

Because WBI acts on material still present within the GI tract, earlier use may provide greater theoretical benefit.

However, extended-release products, bezoars, and packets can remain in the bowel for prolonged periods.

Therefore:

Time since ingestion alone should not determine whether WBI is useful.

The likely location and persistence of the material matter.

⸻

Pregnancy

PEG-electrolyte solutions undergo minimal systemic absorption.

Pregnancy itself is not an absolute contraindication when WBI is otherwise clearly indicated.

The historical FDA pregnancy letter-category system is obsolete.

Management should weigh:

• Maternal poisoning severity
• Aspiration risk
• GI status
• Potential fetal consequences of untreated maternal toxicity

⸻

Children

Children may have greater difficulty tolerating the volume required for WBI.

Important considerations include:

• Vomiting
• Aspiration risk
• Fluid balance
• Electrolytes
• Cooperation
• Size-appropriate administration

WBI should be reserved for situations in which its expected benefit is meaningful.

⸻

Important Modernization of the Older Source

• WBI mechanically removes unabsorbed intestinal contents using iso-osmotic PEG-electrolyte solution.
• It does not adsorb toxins and does not neutralize them chemically.
• Evidence demonstrating improved clinical outcomes is limited, so routine WBI after poisoning is not recommended.
• Important selected uses include substantial sustained-release/enteric-coated ingestions, iron, selected sustained-release lithium exposures, retained toxic foreign material, pharmacobezoars, and body packers.
• WBI should not automatically be used for every heavy-metal ingestion.
• Activated charcoal is ineffective for iron and lithium, which is one reason WBI may occasionally be considered.
• WBI does not treat toxin that has already been absorbed.
• Severe systemic lithium poisoning may require dialysis; severe iron poisoning may require deferoxamine.
• Asymptomatic body packers with intact packets are an important modern indication.
• Suspected packet rupture is an emergency and may require urgent surgical intervention rather than continued WBI alone.
• Body packers and body stuffers should not be managed identically.
• Mechanical obstruction, ileus, perforation, and an unsafe airway are major contraindications.
• Hemodynamic stabilization takes priority over GI decontamination.
• Clear rectal effluent is useful but should not always be the sole treatment endpoint.
• CT is generally more sensitive than plain radiography for detecting body-packer packets.
• Routine simultaneous WBI and activated charcoal is not necessarily beneficial.
• PEG-electrolyte preparations minimize but do not completely eliminate fluid/electrolyte complications.
• Exact irrigation rates and volumes should follow current poison-center or medical-toxicology protocols rather than historical fixed regimens.

Key Points

• WBI = PEG-electrolyte solution → rapid intestinal transit → mechanical elimination of unabsorbed material.
• It is a selective, not routine, gastrointestinal decontamination technique.
• Consider it especially when dangerous material is poorly adsorbed by charcoal or remains physically within the GI tract.
• Important examples include iron, selected sustained-release lithium ingestions, extended-release preparations, pharmacobezoars, and body packers.
• WBI cannot remove toxin that has already been systemically absorbed.
• Do not perform WBI in bowel obstruction, ileus, perforation, or an inadequately protected airway.
• Aspiration and poor GI tolerance are important complications.
• In unstable poisoning, resuscitation and toxin-specific treatment always take priority.